Statements Of Cash Flows (USD $)	9 Months Ended		131 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011
OPERATING ACTIVITIES:
Net loss	$ (1,820,949)	$ (2,109,014)	$ (15,954,096)
Adjustments to reconcile net loss to net cash used in operating activities:
Common stock and long-term debt issued for acquisition of license agreement			2,735,649
Common stock issued for services and amortization of common stock issued for services	834,532	336,654	4,320,480
Options and warrants issued to employees, directors and consultants			614,287
Contribution from shareholder			188,706
Amortization of beneficial conversion feature	7,000	205,436	531,561
Amortization of deferred loan costs			24,750
Write off of deferred offering costs			119,383
Write off of deferred non cash offering costs			49,120
Gain on disposal of fixed assets			(1,965)
Depreciation	3,056	3,516	50,164
Amortization of agency fee	42,632		100,000
Amortization of discount on notes payable			33,858
Increase in prepaid expenses	4,227	(111,211)	(104,665)
Increase (decrease) in:
Accounts payable	47,354	100,283	299,760
Accrued expenses	34,000	31,753	307,250
Accrued payroll	296,622	(59,292)	571,633
Accrued royalty fees	187,500	187,500	1,655,667
Accrued interest		369	14,718
Net cash used by operating activities	(364,026)	(1,414,006)	(4,443,740)
INVESTING ACTIVITIES:
Payment of agency fee rights			(100,000)
Issuance of notes receivable from stockholders			(23,000)
Repayment of notes receivable from stockholders			22,095
Advances to related party			805
Proceeds from sale of fixed assets			2,500
Purchase of fixed assets	(46,954)	(4,459)	(96,883)
Net cash used by investing activities	(46,954)	(4,459)	(194,483)
FINANCING ACTIVITIES:
Repayment of stockholder advances			(157,084)
Advances from stockholders	5,000		271,152
Increase in deferred offering costs			(194,534)
Proceeds from issuance of common stock	236,320	912,317	3,872,793
Proceeds from exercise of options			45,000
Debt issuance costs			(19,750)
Repayment of convertible notes payable			(23,000)
Proceeds from issuance of convertible notes payable	50,000	250,000	852,250
Net cash provided by financing activities	291,320	1,162,317	4,646,827
NET (DECREASE) INCREASE IN CASH	(119,660)	(256,148)	8,604
CASH, BEGINNING OF PERIOD	128,264	603,601
CASH, END OF PERIOD	8,604	347,453	8,604
Supplemental disclosures of cash flow information and noncash investing and financing activities:
Cash paid for interest			21,477
Subscription receivable for issuance of common stock			29,090
Option to acquire license for issuance of common stock			10,000
Deferred offering costs netted against issuance of common stock under private placement			33,774
Deferred offering costs netted against issuance of common stock			41,735
Value of beneficial conversion feature of notes payable			19,507
Deferred non-cash offering costs in connection with private placement			74,850
Application of amount due from shareholder against related party debt			8,099
Amortization of offering costs related to stock for services			25,730
Settlement of notes payable in exchange for common stock			356,466
Common stock issued in exchange for prepaid services		312,150	2,245,164
Common stock issued in exchange for accrued royalties			416,667
Receivable issued for exercise of common stock options	200,000		367,000
Common stock issued in exchange for fixed assets			5,000
Acquisition of agency fee intangible through accrued expenses			900,000
Beneficial conversion feature on convertible notes	7,000	248,889	531,561
Conversion of convertible debt to equity (7,340,152 shares since inception)	50,000	175,000	772,000
Common stock issued for accounts payable	90,313	55,125	180,438
Common stock issued for accrued payroll	15,000	202,000	15,000
Write off uncollectible stock subscription receivable		155,000	155,000
Write off of intangible asset and agency fee payable	$ 900,000		$ 900,000